NCT07553988 A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07545811 Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer Status RECRUITING Phase PHASE1
NCT07476001 Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC Status RECRUITING Phase PHASE2
NCT07423117 A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy Status NOT_YET_RECRUITING Phase PHASE1
NCT07414940 ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium Status RECRUITING Phase PHASE1/PHASE2
NCT07365995 A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE3
NCT07339267 A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer Status RECRUITING Phase PHASE1
NCT07288359 Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07287150 A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer Status RECRUITING Phase PHASE2
NCT07244341 A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) Status RECRUITING Phase PHASE1
NCT07213674 A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE3
NCT07189403 A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE1
NCT07172126 Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07142551 Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response Status RECRUITING Phase PHASE2
NCT07103018 A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001) Status RECRUITING Phase PHASE1
NCT07005154 A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer Status RECRUITING Phase PHASE2
NCT06972628 Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 Status RECRUITING Phase PHASE2
NCT06971211 Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC Status RECRUITING Phase PHASE2